Tag: valeo pharma
-
![Markets slip as CPI remains above expectations 01-16-24]()
Markets slip as CPI remains above expectations 01-16-24
The TSX dipped 1% this morning to 20907.44. TSX Venture fell similarly to 558.82 while the CSE Composite dropped 2.3% to 186.26. CPI numbers remained sticky, dampening hopes of a March rate cut. Valeo Pharma Market segments remained relatively flat with Telecom, Information Technology, Healthcare and Battery Metals marginally in the green. Valeo Pharma (VPH.T)…
-
![Today’s Idea: Valeo Pharma (VPH.C) Boasts an Impressive Portfolio and Achieves Significant Growth]()
Today’s Idea: Valeo Pharma (VPH.C) Boasts an Impressive Portfolio and Achieves Significant Growth
Even during my university days, I would find myself grasping my chest, wheezing after a short 15-minute walk to campus. In terms of fitness, I would consider myself to be above average. With this in mind, I found it startling that I was struggling to do something as trivial as walking to class. Drenched in…
-
![Valeo Pharma (VPH.C) CEO Steve Saviuk talks specialty pharma opportunity (Ep4) Chris’ Corner]()
Valeo Pharma (VPH.C) CEO Steve Saviuk talks specialty pharma opportunity (Ep4) Chris’ Corner
Steve Saviuk, president and CEO of Valeo Pharma (VPH.C), talks about the transformative partnerships with international players such as Novartis and members of the Canadian Healthcare Industry, that allow the company to bring leading innovative products to the Canadian market. Tune in!
-
![Undervalued Valeo Pharma (VPH.C) and their asthma inhalers may be 2021’s shiniest hidden gem]()
Undervalued Valeo Pharma (VPH.C) and their asthma inhalers may be 2021’s shiniest hidden gem
There’s nothing more terrifying than watching a loved one pause, clutch their throat and start gasping for air. The first time it happens provokes the mad scramble, as she points at her purse and mimes the universal L-shaped hand pattern for an asthma inhaler. She sits while you go digging through spent candy wrappers, old…
-
Valeo Pharma (VPH.c) and why you should care about bioflavonoids
Doing what we do at Equity Guru, every day, we receive emails and dms from shareholders of different companies – all expressing their grievances. Disgruntled with various issues such as failed management promises, lackluster progress, heavily diluted share structure, etc… As a result, it makes it even more satisfying to introduce our audience to companies…
